Adaptive Biotechnologies Corporation Common Stock (ADPT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ADPT. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 242 institutions reported holding ADPT, with 86.2 million shares worth $2.5 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 15,302,445 | $442M | INCREASED |
| Vanguard | 12,810,316 | $370M | DECREASED |
| Geode Capital Management | 3,720,520 | $108M | INCREASED |
| State Street | 3,557,289 | $103M | INCREASED |
| Lord Abbett | 3,319,996 | $96M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Julie Rubinstein (President and COO) | EXERCISE | 11,466 | $139K | 2026-11-13 |
| Julie Rubinstein (President and COO) | SELL | 11,466 | $332K | 2026-11-13 |
| Julie Rubinstein (President and COO) | EXERCISE | 11,466 | $139K | 2026-11-13 |
| Julie Rubinstein (President and COO) | EXERCISE | 11,881 | $144K | 2026-11-12 |
| Julie Rubinstein (President and COO) | SELL | 11,881 | $349K | 2026-11-12 |
Full institutional holdings, insider history, and congressional trades for Adaptive Biotechnologies Corporation Common Stock on SentiSense.